...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis
【24h】

Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis

机译:用比色分析法测定人血浆和尿液中的碘海醇,噻吩甲酸酯,对氨基苯丙酸和正乙酰基对氨基苯丙酸的简单HPLC-UV方法

获取原文
获取原文并翻译 | 示例
           

摘要

A simple high-performance liquid chromatographic (HPLC) method was developed for the simultaneous determination of iohexol, iothalamate, p-ammohippuric acid (PAH) and n-acetyl-p-aminohippuric acid (n-acetyl-PAH) in human plasma and urine. A C-18 column at a flow rate of I ml/min with an aqueous mobile phase of trifluoroacetic acid (0.1% TFA in deionized water (pH 2.2), v/v) and methanol gradient was used for component separation. The plasma and urine assay demonstrated linearity from 10 to 50 mu g/ml for iohexol and iothalamate, 5 to 40 mu g/ml for PAH and 2.5 to 40 mu g/ml for n-acetyl-PAH. The HPLC plasma and urine results obtained for PAH were used to calculate the subject kidney effective renal plasma flow (ERPF) and the iohexol results were used to calculate the subject kidney glomerular filtration rate (GFR). The HPLC results for PAH were then compared to an alternative colorimetric method for analyzing PAH to determine if subject metabolism (acetylation) of PAH affected the ERPF results obtained using the colorimetric method, the subsequent ERPF/GFR ratio and clinical impression of subject patient kidney function. The method was utilized in several different clinical studies evaluating the effect of kidney function from medications (phase IV evaluations) marketed for patients with cardiovascular disease. (c) 2005 Elsevier B.V. All rights reserved.
机译:建立了一种简单的高效液相色谱(HPLC)方法,用于同时测定人血浆和尿液中的碘海醇,碘代乙酸酯,对氨基苯尿酸(PAH)和正乙酰基对氨基氨基尿酸(n-乙酰基PAH) 。流速为1 ml / min的C-18色谱柱使用三氟乙酸的水相(0.1%TFA的去离子水溶液(pH 2.2),v / v)和甲醇梯度洗脱,用于组分分离。血浆和尿液分析显示,碘海醇和碘代草酸酯的线性为10至50μg / ml,PAH为5至40μg / ml,正乙酰基PAH为2.5至40μg/ ml。 PAH的HPLC血浆和尿液结果用于计算受试者的肾脏有效肾血浆流量(ERPF),碘海醇结果用于计算受试者的肾小球肾小球滤过率(GFR)。然后将PAH的HPLC结果与另一种比色法进行比较,以分析PAH,以确定PAH的受试者代谢(乙酰化)是否影响使用比色法获得的ERPF结果,随后的ERPF / GFR比以及受试者患者肾功能的临床印象。该方法已用于数项不同的临床研究中,这些药物评估了针对心血管疾病患者的药物对肾脏功能的影响(IV期评估)。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号